Author

Parisa Nikeghbal

University of New MexicoORCID 0000-0002-6954-7544Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:organoid / primary culture· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

Danielle BurkeiD· 2 shared Mara P. SteinkampiD· 2 shared Dalet Armijo· 1 shared Diane S. LidkeiD· 1 shared Dorsa Zamanian· 1 shared S Aldarondo-Quiñones· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

6 top collaborators · 12 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Danielle BurkeORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Organoid Models Derived from Primary Tumors and Patient-Derive Xenograft Tumors Reflect Platinum Sensitivity of Ovarian Cancer Patients

Parisa Nikeghbal, Dorsa Zamanian, Danielle Burke, Mara P. Steinkamp

This study shows that organoids derived from patient-derived xenografts (PDXOs) reflect the chemotherapy response of ovarian cancer patients similarly to organoids directly from primary tumors (PDOs).

BMC Cancer · Sep 30, 2025Peer-reviewedCancer Biology

The Influence of Macrophages within the Tumor Microenvironment on Ovarian Cancer Growth and Response to Therapies

Parisa Nikeghbal, Danielle Burke, Dalet Armijo, S Aldarondo-Quiñones, Diane S. Lidke, Mara P. Steinkamp

This study shows that M2 macrophages in the tumor microenvironment enhance ovarian cancer growth and reduce sensitivity to paclitaxel, and that targeting TAMs with CSF-1R inhibitors can improve treatment outcomes when combined with chemotherapy.

bioRxiv · Jan 29, 2025 · PreprintCancer Biology